Form D · Other Health Care
NFANT Labs, Inc.
Port Richey, FL · CIK 0001594115
Offering snapshot reported Jul 18, 2025 · SEC filing
- Reported sold
- $50K Offering amount: $690K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 18, 2025 | Initial | $50,000 | No comparison | 1 | SEC filing |
| May 10, 2024 | Amendment | $530,280 | $127,280vs Jan 5, 2024 | 8 | SEC filing |
| Jan 5, 2024 | Amendment | $403,000 | $115,500vs Dec 20, 2023 | 6 | SEC filing |
| Dec 20, 2023 | Initial | $287,500 | No comparison | 5 | SEC filing |
| Dec 7, 2023 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Mar 15, 2023 | Amendment | $1,421,000 | $175,000vs Dec 19, 2022 | 17 | SEC filing |
| Dec 19, 2022 | Amendment | $1,246,000 | $185,000vs Oct 20, 2022 | 12 | SEC filing |
| Oct 20, 2022 | Amendment | $1,061,000 | $300,000vs Aug 30, 2022 | 8 | SEC filing |
| Aug 30, 2022 | Amendment | $761,000 | $50,000vs Jun 16, 2022 | 6 | SEC filing |
| Jun 16, 2022 | Amendment | $711,000 | $10,000vs May 9, 2022 | 5 | SEC filing |
| May 9, 2022 | Amendment | $701,000 | $135,000vs Feb 22, 2022 | 4 | SEC filing |
| Feb 22, 2022 | Amendment | $566,000 | $151,000vs Aug 30, 2021 | 1 | SEC filing |
| Aug 30, 2021 | Initial | $415,000 | No comparison | 1 | SEC filing |
| Jun 7, 2018 | Amendment | $612,500 | $462,500vs May 29, 2018 | 8 | SEC filing |
| May 29, 2018 | Initial | $150,000 | No comparison | 8 | SEC filing |
| Dec 13, 2013 | Initial | $125,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-552211
Source: Form D, filed Jul 18, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gilson Capilouto | Director |
| Tommy Cunningham | Director, Executive |
| Thomas Labs Cunningham | Director, Executive |
| Stephen N. Kerth | Director |
| Terri Kline | Director |
| Louis. F. Malice, Jr. | Director, Executive |
| Louis F. Malice, Jr. | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
6016 Sherwin Dr.
Port Richey, FL, 34668
Port Richey, FL, 34668